Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.


Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
25 09 2020
Historique:
entrez: 26 9 2020
pubmed: 27 9 2020
medline: 21 10 2020
Statut: epublish

Résumé

Infectious coronavirus (CoV) disease 2019 (COVID-19) emerged in the city of Wuhan (China) in December 2019, causing a pandemic that has dramatically impacted public health and socioeconomic activities worldwide. A previously unknown coronavirus, severe acute respiratory syndrome CoV-2 (SARS-CoV-2), has been identified as the causative agent of COVID-19. To date, there are no U.S. Food and Drug Administration (FDA)-approved vaccines or therapeutics available for the prevention or treatment of SARS-CoV-2 infection and/or associated COVID-19 disease, which has triggered a large influx of scientific efforts to develop countermeasures to control SARS-CoV-2 spread. To contribute to these efforts, we have developed an infectious cDNA clone of the SARS-CoV-2 USA-WA1/2020 strain based on the use of a bacterial artificial chromosome (BAC). Recombinant SARS-CoV-2 (rSARS-CoV-2) was readily rescued by transfection of the BAC into Vero E6 cells. Importantly, BAC-derived rSARS-CoV-2 exhibited growth properties and plaque sizes in cultured cells comparable to those of the natural SARS-CoV-2 isolate. Likewise, rSARS-CoV-2 showed levels of replication similar to those of the natural isolate in nasal turbinates and lungs of infected golden Syrian hamsters. This is, to our knowledge, the first BAC-based reverse genetics system for the generation of infectious rSARS-CoV-2 that displays features

Identifiants

pubmed: 32978313
pii: mBio.02168-20
doi: 10.1128/mBio.02168-20
pmc: PMC7520601
pii:
doi:

Substances chimiques

DNA, Complementary 0
RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : UpdateOf

Informations de copyright

Copyright © 2020 Ye et al.

Références

Chemotherapy. 2019;64(5-6):215-223
pubmed: 32259829
Proc Natl Acad Sci U S A. 2000 May 9;97(10):5516-21
pubmed: 10805807
Sci Total Environ. 2020 Jul 10;725:138277
pubmed: 32278175
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Anat Rec (Hoboken). 2013 Mar;296(3):378-81
pubmed: 23382140
Sci Rep. 2019 Dec 27;9(1):19968
pubmed: 31882898
Int J Surg. 2020 Apr;76:71-76
pubmed: 32112977
Clin Microbiol Infect. 2020 Apr;26(4):399-400
pubmed: 32058086
J Vis Exp. 2019 Jun 24;(148):
pubmed: 31282877
Cell Host Microbe. 2020 May 13;27(5):841-848.e3
pubmed: 32289263
Gac Med Mex. 2020;156(2):132-137
pubmed: 32285862
Nucleic Acids Res. 2012 Dec;40(22):11189-201
pubmed: 23066108
Sci Rep. 2020 Jan 16;10(1):512
pubmed: 31949262
Nature. 2020 Jun;582(7813):561-565
pubmed: 32365353
J Virol. 2005 Jan;79(1):503-11
pubmed: 15596843
Nature. 2020 Apr 7;:
pubmed: 32265538
Viruses. 2018 Oct 31;10(11):
pubmed: 30384426
J Virol. 2011 Mar;85(6):2927-41
pubmed: 21228244
Curr Opin Virol. 2020 Jul 25;44:66-72
pubmed: 32721864
Infect Dis Poverty. 2020 Apr 7;9(1):34
pubmed: 32264957
Viruses. 2019 Mar 14;11(3):
pubmed: 30875715
Viruses. 2018 Oct 07;10(10):
pubmed: 30301244
mBio. 2013 Sep 10;4(5):e00650-13
pubmed: 24023385
Bioinformatics. 2018 Mar 1;34(5):867-868
pubmed: 29096012
PLoS One. 2010 May 12;5(5):e10611
pubmed: 20485554
Nature. 2020 Jul;583(7818):834-838
pubmed: 32408338
J Vis Exp. 2013 Aug 01;(78):
pubmed: 23928556
J Virol. 1997 Jul;71(7):5366-74
pubmed: 9188607
J Virol. 1992 Sep;66(9):5425-31
pubmed: 1501281
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Fly (Austin). 2012 Apr-Jun;6(2):80-92
pubmed: 22728672
Antiviral Res. 2020 Apr;176:104742
pubmed: 32057769
J Virol. 2014 Sep;88(18):10525-40
pubmed: 24965472
mBio. 2016 Aug 23;7(4):
pubmed: 27555311
J Infect Dev Ctries. 2020 Jan 31;14(1):3-17
pubmed: 32088679
Nat Rev Microbiol. 2016 Aug;14(8):523-34
pubmed: 27344959
Cont Lens Anterior Eye. 2020 Jun;43(3):196-203
pubmed: 32273245
J Virol. 2006 Apr;80(7):3670-4
pubmed: 16537637

Auteurs

Chengjin Ye (C)

Texas Biomedical Research Institute, San Antonio, Texas, USA.

Kevin Chiem (K)

Texas Biomedical Research Institute, San Antonio, Texas, USA.

Jun-Gyu Park (JG)

Texas Biomedical Research Institute, San Antonio, Texas, USA.

Fatai Oladunni (F)

Texas Biomedical Research Institute, San Antonio, Texas, USA.
Department of Veterinary Microbiology, University of Ilorin, Ilorin, Nigeria.

Roy Nelson Platt (RN)

Texas Biomedical Research Institute, San Antonio, Texas, USA.

Tim Anderson (T)

Texas Biomedical Research Institute, San Antonio, Texas, USA.

Fernando Almazan (F)

Department of Molecular and Cell Biology, Centro Nacional de Biotecnología (CNB-CSIC), Madrid, Spain.

Juan Carlos de la Torre (JC)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, USA.

Luis Martinez-Sobrido (L)

Texas Biomedical Research Institute, San Antonio, Texas, USA lmartinez@txbiomed.org.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH